ArticleMolecular oncology2022

The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cells.

Stefania Bartoloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.